Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: Effects on glucose control, plasma IGF-I and glutamine

Growth Hormone and IGF Research

Volumn 18, Issue 1, 2008, Pages 82-87

  Duška, František ^a   Fric, Michal ^a   Pažout, Jaroslav ^a   Waldauf, Petr ^a   Tůma, Petr ^a   Pachl, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Glucose control; Glutamine; Growth hormone; IGF I; Multiple trauma; Prolonged critical illness

Indexed keywords

ALANYLGLUTAMINE; GLUCOSE; GLUTAMINE; HUMAN GROWTH HORMONE; INSULIN; NORDITROPIN SIMPLEXXX; PLACEBO; PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG PULSE THERAPY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN INFUSION; LOW DRUG DOSE; MALE; MULTIPLE TRAUMA; OPEN STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADULT; BLOOD GLUCOSE; CRITICAL ILLNESS; DIPEPTIDES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION ROUTES; FEMALE; GLUTAMINE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MULTIPLE TRAUMA;

EID: 39049146590     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.07.003     Document Type: Article

References (26)

1. Herndon D.N., Barrow R.E., Kunkel K.R., Broemeling L., and Rutan R.L. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann. Surg. 212 4 (1990) 424-429
2. Knox J., Demling R., Wilmore D., Sarraf P., and Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J. Trauma 39 3 (1995) 526-530
3. Fleming R.Y., Rutan R.L., Jahoor F., Barrow R.E., Wolfe R.R., and Herndon D.N. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J. Trauma 32 6 (1992) 698-702
4. Gottardis M., Benzer A., Koller W., Luger T.J., Puhringer F., and Hackl J. Improvement of septic syndrome after administration of recombinant human growth hormone (rhGH)?. J. Trauma 31 1 (1991) 81-86
5. Roth E., Valentini L., Semsroth M., Holzenbein T., Winkler S., Blum W.F., Ranke M.B., Schemper M., Hammerle A., and Karner J. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J. Trauma 38 1 (1995) 136-141
6. de Boer H., Blok G.J., Voerman B., de Vries P., Popp-Snijders C., and van der VeenE E. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis:. JCEM 80 (1995) 2069-2076
7. Takala J., Ruokonen E., Webster N.R., Nielsen M.S., Zandstra D.F., Vundelinckx G., and Hinds C.J. Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 341 11 (1999) 785-792
8. Osterziel K.J., Dietz R., and Ranke M.B. Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 342 2 (2000) 134-135
9. Demling R. Growth hormone therapy in critically ill patients. N. Engl. J. Med. 341 11 (1999) 837-839
10. Biolo G., Iscra F., Bosutti A., Toigo G., Ciocchi B., Geatti O., Gullo A., and Guarnieri G. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. Am. J. Physiol. Endocrinol. Metab. 279 2 (2000) E323-E332
11. van den Berghe G. Increased mortality associated with growth hormone treatment in critically ill adults. NEJM 342 (2000) 134-135
12. Tacke J., Bolder U., and Lohlein D. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery. Infusionsther. Transfusionsmed. 21 1 (1994) 24-29
13. van den Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol. 23 4 (2002) 370-391
14. Kanji S., Singh A., Tierney M., Meggison H., McIntyre L., and Hebert P.C. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med. 30 5 (2004) 804-810
15. Baker S.P. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J. Trauma 14 (1974) 187-196
16. Coufal P., ZuskaJ J., ven de Goor T., Smith V., and Gaš B. Separation of twenty underivatized essential amino acids by capillary zone electrophoresis with contactless conductivity detection. Electroanalysis 13 (2001) 989-992
17. Jennett B., Snoek J., Bond M.R., and Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J. Neurol. Neurosurg. Psychiat. 44 (1981) 285-293
18. Bengtsson B.A. Rethink about growth-hormone therapy for critically ill patients. Lancet 354 9188 (1999) 1403-1404 9188
19. Thissen J.P., Underwood L.E., and Ketelslegers J.M. Regulation of insulin-like growth factor-I in starvation and injury. Nutr. Rev. 57 6 (1999) 167-176
20. Mesotten D., Delhanty P.J., Vanderhoydonc E., Hardman K.V., Weekers F., Baxter R.C., and Van Den Berghe G. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J. Clin. Endocrinol. Metab. 87 12 (2002) 5516-5523
21. Bakalar B., Duska F., Pachl J., Fric M., Otahal M., Pazout J., and Andel M. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit. Care Med. 34 2 (2006) 381-386
22. Mesotten D., Wouters P.J., Peeters R.P., Hardman K.V., Holly J.M., Baxter R.C., and Van den Berghe G. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J. Clin. Endocrinol. Metab. 89 7 (2004) 3105-3113
23. Brismar K., Forbes-Fernqvist E., Wahren J., and Hall K. Effects of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin dependent diabetes. J. Clin. Endocrinol. Metab. 79 (2004) 872-878
24. Umpleby A.M., Carrol P.V., Russell-Jones D.L., Treacher D.F., and Jackson N.C. Glutamine supplementation and GH/IGF-I treatment in critacally ill patients: effects on glutamine metabolism and protein balance. Nutrition 18 (2002) 127-129
25. Andrews F.J., and Griffiths R.D. Glutamine: essential for immune nutrition in the critically ill. Br. J. Nutr. 87 Suppl 1 (2002) S3-S8
26. Coeffier M., and Dechelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome. Nutr. Rev. 63 2 (2005) 65-69